Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study.
about
Advances in Diagnosis and Treatments for Immune ThrombocytopeniaImmune thrombocytopeniaRisk and prognosis of adult primary immune thrombocytopenia.Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care.Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia.Rituximab versus splenectomy in persistent or chronic adult primary immune thrombocytopenia: an adjusted comparison of mortality and morbidity.Immune thrombocytopenia: serum cytokine levels in children and adults.Twenty-year mortality of adult patients with primary immune thrombocytopenia: a Danish population-based cohort study.Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients.How we manage immune thrombocytopenia in the elderly.State of the art - how I manage immune thrombocytopenia.Life-threatening bleeding episodes in primary immune thrombocytopenia: a single-center retrospective study of 169 inpatients.Rate of bleeding-related episodes in elderly patients with primary immune thrombocytopenia: a retrospective cohort study.Management of immune thrombocytopenia: Korean experts recommendation in 2017.Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia.
P2860
Q26738630-12A955AC-DB1B-4A8E-B102-B041D3845CE8Q26830918-1239E3D9-DE7D-4BBF-A3A6-C154EC5DF8BBQ33400566-40E26431-D8D1-4216-8CEB-24A0FA625D3CQ33401083-DA602CEC-3E06-4F93-B1B3-E0E74EDD178FQ33403176-812BDD59-F3E4-4191-BFD9-F5C7C1C04399Q33407785-2C64729A-27AE-46FF-B89E-D137DAFA8CDEQ33410348-753B68BB-9293-40BE-9B67-32128A133E71Q33410589-0B1C8BEC-E758-4019-955F-F966D5474088Q33414365-7CAE4E25-3ACA-47E8-8A3E-51C7534B21B4Q33422858-6FED4B22-8F69-4AD2-8998-EA463B294A66Q33425644-F36C48EF-1773-4149-B769-860B398A9E81Q33430899-05EC3FED-08F2-4774-A354-EE5B17C7BDA6Q33431371-AF1B91C5-2B6C-4A4A-9118-6258ED231E2CQ33440145-74370F43-EE65-4E67-9C5F-B5B9B6F5EFB5Q38624674-1793C721-ACBC-4E46-BEF4-6F07C58E763AQ38658259-405DC0EA-4150-47FE-A35C-9F6175830871Q49624514-D49AFDAF-0C94-41A4-9372-78F42EF7CB43Q53394126-AC279677-AC40-4943-8B9F-155C3BCC11B7
P2860
Characteristics and outcome of immune thrombocytopenia in elderly: results from a single center case-controlled study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Characteristics and outcome of ...... center case-controlled study.
@ast
Characteristics and outcome of ...... center case-controlled study.
@en
type
label
Characteristics and outcome of ...... center case-controlled study.
@ast
Characteristics and outcome of ...... center case-controlled study.
@en
prefLabel
Characteristics and outcome of ...... center case-controlled study.
@ast
Characteristics and outcome of ...... center case-controlled study.
@en
P2093
P2860
P356
P1476
Characteristics and outcome of ...... center case-controlled study.
@en
P2093
Francoise Roudot Thoraval
Laetitia Languille
Marc Michel
Mehdi Khellaf
Odile Beyne Rauzy
Philippe Bierling
P2860
P304
P356
10.1002/AJH.22170
P577
2011-09-28T00:00:00Z